
Tvardi Therapeutics, Inc.
TVRDHealthcare|Biotechnology|US
$0.96
+0.09 (+10.79%)
DCF Value
$2.25
Tangible Book / Share
$0.86
Cash / Share
$1.68
Ownership Breakdown
72.2%
Float
13.3M
Shares Outstanding
9.6M
Float Shares
Major Holders (2)
Combined: 15.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
Insider Trades (61)
Last 4 quarters: 336,500 acquired · 315,658 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shiff Susan Ph.D. | director | Jun 9, 2026 | AWARD | 6,000 | $2.78 | $16.7K | Form 4 |
| Smith Cynthia | director | Jun 9, 2026 | AWARD | 6,000 | $2.78 | $16.7K | Form 4 |
| Shah Sujal | director | Jun 9, 2026 | AWARD | 6,000 | $2.78 | $16.7K | Form 4 |
| HALL WALLACE L JR | director | Jun 9, 2026 | AWARD | 6,000 | $2.78 | $16.7K | Form 4 |
| WYZGA MICHAEL S | director | Jun 9, 2026 | AWARD | 6,000 | $2.78 | $16.7K | Form 4 |
| O'Brien Stephen Paul | Principal Accounting Officer | Jan 29, 2026 | AWARD | 15,000 | $3.90 | $58.5K | Form 4 |
| Conn Avi Daniel | Chief Financial Officer | Jan 29, 2026 | AWARD | 45,000 | $3.90 | $175.5K | Form 4 |
| Kauh John Saewook M.D. | Chief Medical Officer | Jan 29, 2026 | AWARD | 45,000 | $3.90 | $175.5K | Form 4 |
| Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | Jan 29, 2026 | AWARD | 115,000 | $3.90 | $448.5K | Form 4 |
| O'Brien Stephen Paul | Principal Accounting Officer | Dec 16, 2025 | AWARD | 4,000 | $4.20 | $16.8K | Form 4 |
| Kauh John Saewook M.D. | Chief Medical Officer | Dec 16, 2025 | AWARD | 17,500 | $4.20 | $73.5K | Form 4 |
| Conn Avi Daniel | Chief Financial Officer | Dec 16, 2025 | AWARD | 17,500 | $4.20 | $73.5K | Form 4 |
| Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | Dec 16, 2025 | AWARD | 47,500 | $4.20 | $199.5K | Form 4 |
| Tweardy Samuel David | 10 percent owner | Jul 7, 2025 | DISPOSED | 315,658 | — | — | Form 4 |
| HALL WALLACE L JR | director | Apr 15, 2025 | AWARD | 202,044 | — | — | Form 4 |
| HALL WALLACE L JR | director | Apr 15, 2025 | AWARD | 44,712 | — | — | Form 4 |
| Wirk Shaheen | director | Apr 15, 2025 | AWARD | 263,164 | — | — | Form 4 |
| Wirk Shaheen | director | Apr 15, 2025 | AWARD | 176,030 | — | — | Form 4 |
| Tweardy Samuel David | 10 percent owner | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 |
| Larson Jeffrey Leroy | SVP, Research & Development | Apr 17, 2025 | AWARD | 10,820 | $17.04 | $184.4K | Form 4 |
| O'Brien Stephen Paul | Principal Accounting Officer | Apr 17, 2025 | AWARD | 7,213 | $17.04 | $122.9K | Form 4 |
| Chen Yixin | VP, Chem, Mfg and Ctrls | Apr 17, 2025 | AWARD | 7,213 | $17.04 | $122.9K | Form 4 |
| Conn Avi Daniel | Chief Financial Officer | Apr 17, 2025 | AWARD | 43,547 | $17.04 | $742.0K | Form 4 |
| Kauh John Saewook M.D. | Chief Medical Officer | Apr 17, 2025 | AWARD | 36,210 | $17.04 | $617.0K | Form 4 |
| Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | Apr 17, 2025 | AWARD | 182,320 | $17.04 | $3.1M | Form 4 |
| Shiff Susan Ph.D. | director | Apr 17, 2025 | AWARD | 12,000 | $17.04 | $204.5K | Form 4 |
| Wirk Shaheen | director | Apr 17, 2025 | AWARD | 12,000 | $17.04 | $204.5K | Form 4 |
| WYZGA MICHAEL S | director | Apr 17, 2025 | AWARD | 12,000 | $17.04 | $204.5K | Form 4 |
| Smith Cynthia | director | Apr 17, 2025 | AWARD | 12,000 | $17.04 | $204.5K | Form 4 |
| Shah Sujal | director | Apr 17, 2025 | AWARD | 12,000 | $17.04 | $204.5K | Form 4 |
| HALL WALLACE L JR | director | Apr 17, 2025 | AWARD | 12,000 | $17.04 | $204.5K | Form 4 |
| O'Brien Stephen Paul | Principal Accounting Officer | Apr 15, 2025 | AWARD | 11,399 | $4.70 | $53.6K | Form 4 |
| O'Brien Stephen Paul | Principal Accounting Officer | Apr 15, 2025 | AWARD | 3,352 | $6.86 | $23.0K | Form 4 |
| HALL WALLACE L JR | director | Apr 15, 2025 | J | 202,044 | — | — | Form 4 |
| HALL WALLACE L JR | director | Apr 15, 2025 | J | 44,712 | — | — | Form 4 |
| Kauh John Saewook M.D. | Chief Medical Officer | Apr 15, 2025 | AWARD | 74,049 | $6.12 | $453.2K | Form 4 |
| WYZGA MICHAEL S | director | Apr 15, 2025 | AWARD | 18,441 | $4.70 | $86.7K | Form 4 |
| Chen Yixin | VP, Chem, Mfg and Ctrls | Apr 15, 2025 | AWARD | 14,752 | $4.70 | $69.3K | Form 4 |
| Wirk Shaheen | director | Apr 15, 2025 | J | 263,164 | — | — | Form 4 |
| Wirk Shaheen | director | Apr 15, 2025 | J | 176,030 | — | — | Form 4 |
| Wirk Shaheen | director | Apr 15, 2025 | AWARD | 4,191 | — | — | Form 4 |
| Wirk Shaheen | director | Apr 15, 2025 | AWARD | 2,011 | $0.68 | $1.4K | Form 4 |
| Shah Sujal | director | Apr 15, 2025 | AWARD | 10,394 | $0.68 | $7.1K | Form 4 |
| Shah Sujal | director | Apr 15, 2025 | AWARD | 8,047 | $4.70 | $37.8K | Form 4 |
| Larson Jeffrey Leroy | SVP, Research & Development | Apr 15, 2025 | AWARD | 16,764 | $0.68 | $11.4K | Form 4 |
| Larson Jeffrey Leroy | SVP, Research & Development | Apr 15, 2025 | AWARD | 5,364 | $4.70 | $25.2K | Form 4 |
| Conn Avi Daniel | Chief Financial Officer | Apr 15, 2025 | AWARD | 89,053 | $4.70 | $418.5K | Form 4 |
| Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | Apr 15, 2025 | AWARD | 207,881 | $0.68 | $141.4K | Form 4 |
| Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | Apr 15, 2025 | AWARD | 160,940 | $4.70 | $756.4K | Form 4 |
| Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | Apr 15, 2025 | AWARD | 2,011 | $0.68 | $1.4K | Form 4 |
| O'Brien Stephen Paul | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| WYZGA MICHAEL S | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| HALL WALLACE L JR | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Wirk Shaheen | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Conn Avi Daniel | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Shah Sujal | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Kauh John Saewook M.D. | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Alibhai Imran Nizamudin | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Smith Cynthia | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Chen Yixin | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 | |
| Larson Jeffrey Leroy | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 |